RECENT COMMENTS

Jose Gros-Aymerich, MD: This is a relapsing-remitting subject. Not long ago, another TKI got EMEA approval for pancreatic ca [...]   »Read more

Richard: Excellent article, but the danger of focussing on one success story is that we can't see the bigger [...]   »Read more

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Subscribe to Cancer World magazine

Cancer World is a free publication. If you would like to be added to our mailing list, please complete the form below and you will receive Cancer World starting from the next issue.

Name:
Surname:
Title:
E-mail:
Phone:
Mailing Address (work or personal)
Hospital:
Department:
Street Address:
Town:
Zip:
Country:
Professional Data
Specialty:
Position:
Main Field:

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR184 - Rethinking the metastatic cascade as a therapeutic target (based on a review article of Nature Reviews Clinical Oncology)

GR185 - Recent advances in the treatment of advanced cervical cancer

GR17 - New accomplishments in breast cancer chemoprevention

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.